World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 18 April 2017
Main ID:  ChiCTR-IPR-15006366
Date of registration: 2015-05-05
Prospective Registration: No
Primary sponsor: Tianjin Medical University
Public title: Improve the Outcome of Glycemic Control by Enhance the Diabetic Patients' Awareness of Risk: A Randomized Double-blind Controlled Trial
Scientific title: Improve the Outcome of Glycemic Control by Enhance the Diabetic Patients' Awareness of Risk: A Randomized Double-blind Controlled Trial
Date of first enrolment: 2015-04-27
Target sample size: 1:40;2:40;
Recruitment status: Recruiting
URL:  http://www.chictr.org.cn/showproj.aspx?proj=10925
Study type:  Interventional study
Study design:  Randomized parallel controlled trial  
Phase:  Pilot study
Countries of recruitment
China
Contacts
Name: Yingying Xiang   
Address:  22 Qi Xiangtai Rd, Tianjin, China 300070
Telephone: +86 13612043240
Email: lovexiangyingying@163.com
Affiliation:  Tianjin Medical University
Name: Zhongming Wu   
Address:  22 Qi Xiangtai Rd, Tianjin, China 300070
Telephone: +86 13672093136
Email: wuzhongming@tmu.edu.cn
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Outpatients in line with diagnostic criteria for type 2 diabetes;
2. The duration of diabetes is over 1 year,whitout obvious diabetes complications;
3. Combined with diet, exercise and the current regimen, blood glucose is still poorly controlled,HbA1C>=7.5%;
4. Age 30 to 70 years.

Exclusion criteria: 1. Type 1 diabetes or secondary diabetes;
2. Gestational diabetes, lactational diabetes and diabetes planning to be pregnant;
3. With any major psychiatric disorder;
4. Alcohol or psychoactive substance abusers and addicts;
5. With resistant hypertension;
6. According to the judgment of researchers, it will reduce the possibility to participate the study or make the participating more complex, for example, change the work or living environment frequently.


Age minimum: 30
Age maximum: 70
Gender: Both
Health Condition(s) or Problem(s) studied
Type 2 Diabetes Mellitus
Intervention(s)
1:Intensive Education;2:Gneral Education;
Primary Outcome(s)
HbA1C;Fasting blood glucose;2 hour postprandial blood glucose;SDSCA;
Secondary Outcome(s)
Body weight;serum lipid;
Secondary ID(s)
Source(s) of Monetary Support
The patients will pay for the costs of the drugs and tests demanded by this clinical trial
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history